Zhen‐Bin Qiu

485 total citations
25 papers, 206 citations indexed

About

Zhen‐Bin Qiu is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Zhen‐Bin Qiu has authored 25 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Zhen‐Bin Qiu's work include Lung Cancer Diagnosis and Treatment (13 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Zhen‐Bin Qiu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Zhen‐Bin Qiu collaborates with scholars based in China, United States and Switzerland. Zhen‐Bin Qiu's co-authors include Wen‐Zhao Zhong, Chao Zhang, Yi‐Long Wu, Xiangpeng Chu, Lei Wei, Hairong Lv, Xuegong Zhang, Rui Fu, Sijie Chen and Xue‐Ning Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Zhen‐Bin Qiu

21 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhen‐Bin Qiu China 9 114 88 71 22 21 25 206
Danielle Power United Kingdom 6 97 0.9× 115 1.3× 50 0.7× 17 0.8× 13 0.6× 11 168
Yikai Xu China 4 83 0.7× 119 1.4× 53 0.7× 28 1.3× 38 1.8× 6 217
Mohamed Zaid United States 8 35 0.3× 54 0.6× 74 1.0× 18 0.8× 38 1.8× 24 175
Tuğçe Kütük United States 8 112 1.0× 34 0.4× 42 0.6× 14 0.6× 19 0.9× 42 167
E.I. Eboulet Switzerland 9 125 1.1× 59 0.7× 76 1.1× 12 0.5× 9 0.4× 15 171
Adeline Cuggia Canada 5 47 0.4× 81 0.9× 134 1.9× 33 1.5× 20 1.0× 5 159
Jingya Han China 8 143 1.3× 194 2.2× 80 1.1× 33 1.5× 58 2.8× 19 296
Qing Bi China 7 49 0.4× 34 0.4× 63 0.9× 26 1.2× 31 1.5× 8 148
Xiangpeng Chu China 8 105 0.9× 32 0.4× 48 0.7× 23 1.0× 45 2.1× 26 191
Shinya Katsumata Japan 10 379 3.3× 195 2.2× 89 1.3× 29 1.3× 17 0.8× 21 406

Countries citing papers authored by Zhen‐Bin Qiu

Since Specialization
Citations

This map shows the geographic impact of Zhen‐Bin Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen‐Bin Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen‐Bin Qiu more than expected).

Fields of papers citing papers by Zhen‐Bin Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen‐Bin Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen‐Bin Qiu. The network helps show where Zhen‐Bin Qiu may publish in the future.

Co-authorship network of co-authors of Zhen‐Bin Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen‐Bin Qiu. A scholar is included among the top collaborators of Zhen‐Bin Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen‐Bin Qiu. Zhen‐Bin Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Zhen‐Bin, Hongji Li, Chao Zhang, et al.. (2025). Quantifying Early-Stage Lung Adenocarcinoma Progression with a Radiomic Trajectory. npj Digital Medicine. 8(1). 664–664.
2.
Ding, Jian‐Yong, Qiang Nie, Zhen‐Bin Qiu, et al.. (2025). Advantages of robotic-assisted thoracic surgery after neoadjuvant therapy in NSCLC: A propensity score–matched analysis. European Journal of Surgical Oncology. 51(8). 110022–110022.
3.
Qiu, Zhen‐Bin, Xiangpeng Chu, Yabin Hu, et al.. (2024). EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in Patients with Pulmonary Ground-Glass Opacities. Annals of Surgical Oncology. 32(7). 4641–4649. 1 indexed citations
4.
5.
Li, Hongji, Zhen‐Bin Qiu, Chao Zhang, et al.. (2024). Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma. Journal of Thoracic Oncology. 20(1). 52–64. 8 indexed citations
6.
Li, Hongji, Zhen‐Bin Qiu, Chao Zhang, et al.. (2023). Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer. European Journal of Cardio-Thoracic Surgery. 64(6). 3 indexed citations
7.
8.
Qiu, Zhen‐Bin, Chao Zhang, Wen‐Fang Tang, et al.. (2023). Proteomic characteristics of lung adenocarcinoma tumors that are small but highly invasive. SHILAP Revista de lepidopterología. 1(4). 340–352. 5 indexed citations
9.
Chu, Xiangpeng, Shaohong Huang, Xiao Yi, et al.. (2023). A novel image deep learning–based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign. European Radiology. 34(3). 2048–2061. 9 indexed citations
10.
Qiu, Zhen‐Bin, Chao Zhang, Sijie Chen, et al.. (2022). ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features. European Radiology. 33(2). 893–903. 39 indexed citations
11.
Qiu, Zhen‐Bin, Chunwen Zheng, Ruijie Zeng, et al.. (2022). Neoadjuvant Therapy for Locally Advanced Esophageal Cancers. Frontiers in Oncology. 12. 734581–734581. 13 indexed citations
12.
Fu, Rui, Jia‐Tao Zhang, Rongrong Chen, et al.. (2022). Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk. Translational Lung Cancer Research. 11(4). 509–522. 6 indexed citations
13.
Qiu, Zhen‐Bin, Chao Zhang, Rui Fu, et al.. (2022). Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25. Thoracic Cancer. 13(22). 3174–3182. 5 indexed citations
14.
Chen, Zhiyong, Rui Fu, Xiaoyue Tan, et al.. (2022). Dynamic 18F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer. Thoracic Cancer. 13(17). 2524–2531. 16 indexed citations
15.
Qiu, Zhen‐Bin, Jinhai Yan, Chao Zhang, et al.. (2022). A Novel Radiopathological Grading System to Tailor Recurrence Risk for Pathologic Stage IA Lung Adenocarcinoma. Seminars in Thoracic and Cardiovascular Surgery. 35(3). 594–602. 2 indexed citations
16.
Chu, Xiangpeng, Jia‐Tao Zhang, Zhaowen Qiu, et al.. (2021). Watershed analysis of the target pulmonary artery for real-time localization of non-palpable pulmonary nodules. Translational Lung Cancer Research. 10(4). 1711–1719. 8 indexed citations
17.
Qiu, Zhen‐Bin, Chao Zhang, Xiangpeng Chu, et al.. (2020). Quantifying invasiveness of clinical stage IA lung adenocarcinoma with computed tomography texture features. Journal of Thoracic and Cardiovascular Surgery. 163(3). 805–815.e3. 14 indexed citations
18.
Tang, Wen‐Fang, Jun‐Tao Lin, Jinghua Chen, et al.. (2020). A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer. Frontiers in Oncology. 10. 1503–1503. 3 indexed citations
19.
Qiu, Zhen‐Bin, et al.. (2019). Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer. Experimental Hematology and Oncology. 8(1). 19–19. 36 indexed citations
20.
Zeng, Jun, Dangui Zhang, Shimin Zheng, et al.. (2019). Compromised Air Quality and Healthcare Safety from Smoking inside Hospitals in Shantou, China. Scientific Reports. 9(1). 7955–7955.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danielle Power Breakdown of academic impact, for papers by Yikai Xu Breakdown of academic impact, for papers by Mohamed Zaid Breakdown of academic impact, for papers by Tuğçe Kütük Breakdown of academic impact, for papers by E.I. Eboulet Breakdown of academic impact, for papers by Adeline Cuggia Breakdown of academic impact, for papers by Jingya Han Breakdown of academic impact, for papers by Qing Bi Breakdown of academic impact, for papers by Xiangpeng Chu Breakdown of academic impact, for papers by Shinya Katsumata
Rankless by CCL
2026